Overall rank by patents
#805
Across all tracked assignees
USPTO PatentsView assignee record - 572 granted patents across 63 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Gyrus holds 572 US patents across 63 technology areas, rank #805 of 50,000 tracked assignees.
Gyrus ACMI, Inc. has been granted 572 US utility patents between 2015 and 2025, placing Gyrus ACMI, Inc. at rank #805 across all assignees tracked by PlainPatent. This portfolio spans 63 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Gyrus ACMI, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Gyrus sits between THE Texas A&M University System (575 patents, rank #801) and The Cleveland Clinic Foundation (570 patents, rank #809) - the closest US assignees by grant volume. The composite Innovation Score of 67.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 405 grants, compared with 167 in the 2015–2019 window, a +143% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Gyrus ACMI, Inc.'s 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 63 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gyrus ACMI, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
THE TEXAS A&M UNIVERSITY SYSTEM
575 patents
The University of North Carolina at Chapel Hill
575 patents
Nutanix, Inc.
574 patents
Silergy Semiconductor Technology (Hangzhou) Ltd.
574 patents
Gyrus ACMI, Inc.
572 patents
Honor Device Co., Ltd.
571 patents
MTU Aero Engines AG
571 patents
Getac Technology Corporation
570 patents
The Cleveland Clinic Foundation
570 patents
What this shows Gyrus holds 572 patents at rank #805, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #805 in granted patent volume.
Other assignees with the most granted patents in Gyrus's primary technology class.
Gyrus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
68 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 22 | 3.8% |
| 2016 | 36 | 6.3% |
| 2017 | 37 | 6.5% |
| 2018 | 38 | 6.6% |
| 2019 | 34 | 5.9% |
| 2020 | 47 | 8.2% |
| 2021 | 58 | 10.1% |
| 2022 | 58 | 10.1% |
| 2023 | 74 | 12.9% |
| 2024 | 100 | 17.5% |
| 2025 | 68 | 11.9% |
Top 15 of 63 technology areas
Overall rank by patents
#805
Across all tracked assignees
67.8 out of 100
How to use this portfolio
Gyrus's 572 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.